Assembly Biosciences Inc (NASDAQ:ASMB)

14.30
Delayed Data
As of 4:00pm ET
 -0.52 / -3.51%
Today’s Change
4.25
Today|||52-Week Range
17.00
+81.93%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Pharmaceuticals: Other
MARKET CAP
$157.8M

Company Description

Assembly Biosciences, Inc. operates as a biopharmaceutical company which develops novel treatments for hepatitis B virus infection and C. difficile-associated diarrhea. It specializes in the development of therapies for infectious diseases like HIV, CDAD and other disorders of the gastrointestinal system including of late-stage and pre-clinical prescription drugs and biologics. The company was founded on October 7, 2005 and is headquartered in New York, NY.

Contact Information

Assembly Biosciences, Inc.
99 Hudson Street
New York New York 10013
P:(646) 706-5208
Investor Relations:

Employees

Shareholders

Mutual fund holders6.70%
Other institutional33.71%
Individual stakeholders15.79%

Top Executives

Derek A. SmallPresident, Chief Executive Officer & Director
David J. BarrettChief Operating & Financial Officer
Lee D. ArnoldChief Scientific Officer
Uri A. LopatinCo-Chief Medical Officer, Vice President-R&D
J. P. BenyaVice President-Corporate Development

To view my watchlist

Not a member yet?

Sign up now for a free account